On December 4, Maha Kabbash was a panelist at the 29th Annual Conference on Drug & Medical Device Litigation sponsored by the American Conference Institute (ACI) in New York City. The panelists discussed navigating the 2023 Amendments to Federal Rule of Evidence 702, which reinforce the critical gatekeeping role of the Court in admitting expert testimony, and shared winning strategies for leveraging the amendments to enhance litigation strategy and secure more favorable outcomes.